{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:36Z","timestamp":1767676776818,"version":"3.41.2"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>In this review, we discuss recent studies showing the importance of the complement pathway in kidney disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent findings in C3 glomerulopathy (C3G) include: acute postinfectious glomerulonephritis is characterised by the presence of antifactor B antibodies; human leukocyte antigen type, but not rare complement gene variation, is associated with primary immunoglobulin-associated membranoproliferative GN and C3G. Immunohistochemistry in C3G shows that factor H related protein 5 (FHR5) is the most prevalent complement protein and correlates with kidney function. A multicentre study supported the use of mycophenolate mofetil (MMF) in C3G even after a propensity matching analysis. In immunoglobulin A nephropathy (IgAN) several studies have emphasised the importance of complement. Imbalances of circulating FH and FHR1 and FHR5, which interfere with the regulatory functions of FH, associate with IgAN. Immunohistochemistry has shown associations between glomerular FHR5 deposition and C3 activation; glomerular FHR5 associated with clinical markers of IgAN severity. Data also suggest the lectin complement pathway contributes to IgAN severity. We also discuss complement activation in thrombotic microangiopathy and other kidney diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Complement activity can be detected in a wide range of kidney diseases and this provides pathogenic insight and potential for therapy with the ongoing development of several drugs directed at complement activation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnh.0000000000000705","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T04:09:02Z","timestamp":1616731742000},"page":"310-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Complement and kidney disease, new insights"],"prefix":"10.1097","volume":"30","author":[{"given":"Nicholas R.","family":"Medjeral-Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Pickering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Terence","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","article-title":"Complement system Part II: role in immunity","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrneph.2017.156","article-title":"The renaissance of complement therapeutics","volume":"14","author":"Ricklin","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ndt\/gfu317","article-title":"Update on C3 glomerulopathy","volume":"31","author":"Barbour","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/ki.2013.340","article-title":"Toward a working definition of C3 glomerulopathy by immunofluorescence","volume":"85","author":"Hou","year":"2014","journal-title":"Kidney Int"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.2017030258","article-title":"Cluster analysis identifies distinct pathogenetic patterns in C3 glomerulopathies\/immune complex-mediated membranoproliferative GN","volume":"29","author":"Iatropoulos","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1681\/ASN.2016030343","article-title":"Anti-Factor B and anti-C3b autoantibodies in C3 glomerulopathy and Ig-associated membranoproliferative GN","volume":"28","author":"Marinozzi","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1681\/ASN.2019080851","article-title":"Anti-Factor B antibodies and acute postinfectious GN in children","volume":"31","author":"Chauvet","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1681\/ASN.2012020166","article-title":"A hybrid CFHR3-1 gene causes familial C3 glomerulopathy","volume":"23","author":"Malik","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1172\/JCI68280","article-title":"C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation","volume":"123","author":"Tortajada","year":"2013","journal-title":"J Clin Investig"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ki.2013.348","article-title":"A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry","volume":"85","author":"Medjeral-Thomas","year":"2014","journal-title":"Kidney Int"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"25168","DOI":"10.1074\/jbc.272.40.25168","article-title":"Human factor H deficiency. Mutations in framework cysteine residues and block in H protein secretion and intracellular catabolism","volume":"272","author":"Ault","year":"1997","journal-title":"J Biol Chem"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation","volume":"120","author":"Martinez-Barricarte","year":"2010","journal-title":"J Clin Investig"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1681\/ASN.2019040433","article-title":"Large-Scale Whole-genome sequencing reveals the genetic architecture of primary membranoproliferative GN and C3 glomerulopathy","volume":"31","author":"Levine","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/his.13385","article-title":"Diagnostic accuracy of immunofluorescence versus immunoperoxidase staining to distinguish immune complex-mediated glomerulonephritis and C3 dominant glomerulopathy","volume":"72","author":"Bouatou","year":"2018","journal-title":"Histopathology"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1681\/ASN.2014040406","article-title":"C4d as a diagnostic tool in proliferative GN","volume":"26","author":"Sethi","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ekir.2019.02.006","article-title":"Glomerular C4d staining does not exclude a C3 glomerulopathy","volume":"4","author":"Singh","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ekir.2019.06.008","article-title":"Glomerular complement factor H-related protein 5 (FHR5) is highly prevalent in C3 glomerulopathy and associated with renal impairment","volume":"4","author":"Medjeral-Thomas","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41379-019-0348-z","article-title":"Utility of immunohistochemistry with C3d in C3 glomerulopathy","volume":"33","author":"Snijders","year":"2020","journal-title":"Mod Pathol"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.kint.2018.09.027","article-title":"Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis","volume":"95","author":"Wilson","year":"2019","journal-title":"Kidney Int"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u2018Kidney Disease: Improving Global Outcomes\u2019 (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2215\/CJN.15241219","article-title":"Mycophenolate mofetil in C3 glomerulopathy and pathogenic drivers of the disease","volume":"15","author":"Caravaca-Fontan","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molimm.2019.07.017","article-title":"The role of complement in IgA nephropathy","volume":"114","author":"Tortajada","year":"2019","journal-title":"Mol Immunol"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12014-017-9165-x","article-title":"Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy","volume":"14","author":"Paunas","year":"2017","journal-title":"Clin Proteom"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1681\/ASN.2016101103","article-title":"Transcriptomic and proteomic profiling provides insight into mesangial cell function in IgA nephropathy","volume":"28","author":"Liu","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.kint.2017.03.043","article-title":"Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy","volume":"92","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.kint.2017.03.041","article-title":"Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy","volume":"92","author":"Tortajada","year":"2017","journal-title":"Kidney Int"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.kint.2018.02.023","article-title":"Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy","volume":"94","author":"Zhu","year":"2018","journal-title":"Kidney Int"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ekir.2017.11.015","article-title":"Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3 (MASP-3) and increased glomerular factor H-related protein-5 (FHR5) deposition","volume":"3","author":"Medjeral-Thomas","year":"2018","journal-title":"Kidney Int Rep"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41379-019-0259-z","article-title":"Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis","volume":"32","author":"Chua","year":"2019","journal-title":"Mod Pathol"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1681\/ASN.2017010076","article-title":"Mannose-binding lectin levels could predict prognosis in IgA nephropathy","volume":"28","author":"Guo","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/HYPERTENSIONAHA.119.13714","article-title":"Diagnostic and risk factors for complement defects in hypertensive emergency and thrombotic microangiopathy","volume":"75","author":"Timmermans","year":"2020","journal-title":"Hypertension"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ekir.2019.07.015","article-title":"Epidemiology and pathophysiology of glomerular C4d staining in native kidney biopsies","volume":"4","author":"Drachenberg","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.diabet.2018.08.011","article-title":"Complement deposition on renal histopathology of patients with diabetic nephropathy","volume":"45","author":"Sun","year":"2019","journal-title":"Diabetes Metab"}],"container-title":["Current Opinion in Nephrology &amp; Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0000000000000705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:09:35Z","timestamp":1753830575000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0000000000000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0000000000000705","relation":{},"ISSN":["1062-4821","1473-6543"],"issn-type":[{"type":"print","value":"1062-4821"},{"type":"electronic","value":"1473-6543"}],"subject":[],"published":{"date-parts":[[2021,3,11]]}}}